- Deaths reported after the administration of the AstraZeneca jab.
- Rare blood-clotting complication could be the reason for deaths.
- The UK health regulator urges people to take the coronavirus vaccine, cause of clotting not found yet.
After more than a year the coronavirus pandemic started spreading full swing across the globe, vaccines from different companies are being administered across the world. With different countries selecting different vaccines to be administered, there's a lot of confusion about which is the safest and the most effective.
Image Source: Copyright © 2021 Kalkine Media Pty Ltd
Recently, the medicines regulator in Britain has urged people to continue taking the AstraZeneca vaccine shots.. This comes even after there has been more than seven deaths post vaccination. The reason for the same was discovered to be the complications which create blood clots after the administration of the vaccine. The medicines and healthcare Regulatory agency revealed that rigorous testing on this matter was underway. Meanwhile, the regulator has also urged the people to keep taking the vaccine as it can't be determined whether the vaccine is responsible for the clotting.
How many cases have been witnessed so far?
Till now, there has been the identification of 30 cases of the rare variety of blood clotting, out of as many as 18,000,000 shots that have been administered so far, so the risk associated is said to be small.
The other vaccines currently being used in vaccinating the British population is Pfizer/BioNtech. It was further revealed that other vaccine brands are also soon going to be made available in the country, which will be enough to vaccinate the entire population.
Statistically, as many as 31 million first jab and 5.2 million second jabs have been delivered in the country.
What are the other countries doing?
Germany has made AstraZeneca available only for the elderly. The country recently halted administering AstraZeneca jab to anyone below the age of 60 years due to the risk of similar clotting symptoms. Other counties such as the Netherlands, France, and Canada have also followed the suite and have restricted the use of these vaccines only for people above the age of 60.
While the U.K. was swifter than the European countries to roll out the vaccine, it is largely dependent on AstraZeneca for the same, which has been created by scientists at the Oxford University.
In terms of reliability, New Zealand chose the Pfizer/BioNTech Vaccine. While priority candidates shall be administered the shot in the month of May, which includes Maoris besides the frontliners, the general population is set to receive the vaccine in the month of July.